Program Leaders Levi S. Downs, Jr., M.D., M.S., (left) and Carol Lange, Ph.D.

Members of this program work to improve detection, treatment, and prevention of women's cancers in order to improve outcomes. Toward that end, they seek to discover improved methods for early detection, understand the biology of breast and gynecologic cancers, and enhance treatment through more precisely targeted therapies.

Program News

U of M Masonic Cancer Center launches ISPY 2 clinical trial
Researchers at the Masonic Cancer Center are participating in a leading-edge breast cancer clinical trial that is designed to test the effectiveness of new targeted therapies that could improve outcomes for women with early-stage breast cancer.

I-SPY2 is a clinical trial that will compare the effectiveness of several potential new breast cancer medicaitions in a single clinical trial and almost immediately evaluate whether they're working. Read more.

October is Breast Cancer Awareness Month: News, Events, Resources

U of M research study shows more Twin Cities breast cancer patients choosing to have healthy breasts removed

Putting ovarian cancer into remission (Minnesota Medical Foundation)

An altruistic attitude: Health-care professionals and patients partner up to advance medical knowledge through clinical research (Minnesota Medical Foundation)

U of M study finds more women diagnosed with early-stage, highly treatable form of breast cancer choosing to have both breasts removed

Recognition Program highlights accomplishments, awards key individuals in Women's Cancer Research Program

Researchers awarded grants from the Minnesota Ovarian Cancer Alliance

Health Talk & You: Another Weapon to Fight Ovarian Cancer

U of M study finds thalidomide shows promise for treatment of recurrent ovarian cancer